A number of countries in Latin America and the Caribbean - including Argentina, Brazil, Chile, Cuba, the Dominican Republic, Guyana, Mexico, Nicaragua and Uruguay - have made major progress in expanding the availability of antiretroviral treatment (ART) for people with HIV, saving the lives of thousands and preventing many new infections, the Pan American Health Organization/World Health Organization (PAHO/WHO) reports in a series of country-specific data analyses published this week.
Several countries, however, face major “treatment gaps” that leave many people who need HIV medication without access to it. Overcoming these gaps will require improvements in early diagnosis, referrals, and monitoring of HIV patients, as well as greater efficiency in the procurement and use of ART, PAHO/WHO analysts say.
The series of fact sheets released this week provide data on the HIV epidemic in 32 countries and territories of the Americas. Details are provided on HIV prevalence, the percentage of HIV patients on ART, public spending on ART, HIV mortality, HIV-tuberculosis co-infections, and other key aspects of the epidemic.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze